South Korea to approve AstraZeneca vaccine for the elderly despite data concerns

Read More

The decision comes despite a warning by the country’s advisory panels on its efficacy for people older than 65 because of lack of data

The decision comes despite a warning by the country’s advisory panels on its efficacy for people older than 65 because of lack of data

Leave a Reply

Your email address will not be published. Required fields are marked *